Observations on models used for the evaluation of antiarrhythmic drugs.
D000470:Alkaloids / Q000037:antagonists & inhibitors; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000139:chemically induced; D001282:Atrial Flutter / Q000139:chemically induced; D001285:Atropine / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D001949:Bretylium Compounds / Q000627:therapeutic use; D002744:Chlorpheniramine / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004195:Disease Models, Animal; D004285:Dogs; D004336:Drug Antagonism; D006168:Guinea Pigs; D007099:Imipramine / Q000627:therapeutic use; D007659:Ketones / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008614:Meperidine / Q000627:therapeutic use; D008616:Mephentermine / Q000627:therapeutic use; D010042:Ouabain / Q000037:antagonists & inhibitors; D010646:Phentolamine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011395:Promazine / Q000627:therapeutic use; D011398:Promethazine / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use
D000470:Alkaloids; D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D001949:Bretylium Compounds; D007659:Ketones; D002744:Chlorpheniramine; D010042:Ouabain; D010672:Phenytoin; D001285:Atropine; D008012:Lidocaine; D008614:Meperidine; D011433:Propranolol; D011398:Promethazine; D011802:Quinidine; D011342:Procainamide; D011395:Promazine; D007099:Imipramine; D003975:Diazepam; D008616:Mephentermine; D010646:Phentolamine